These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 23157228)
21. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma. Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells. Li G; Wu Z; Peng Y; Liu X; Lu J; Wang L; Pan Q; He ML; Li XP Cancer Lett; 2010 Dec; 299(1):29-36. PubMed ID: 20732742 [TBL] [Abstract][Full Text] [Related]
23. MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma. Peng XH; Huang HR; Lu J; Liu X; Zhao FP; Zhang B; Lin SX; Wang L; Chen HH; Xu X; Wang F; Li XP Mol Cancer; 2014 Aug; 13():186. PubMed ID: 25098939 [TBL] [Abstract][Full Text] [Related]
24. Identification of RKIP as an invasion suppressor protein in nasopharyngeal carcinoma by proteomic analysis. Chen Y; Ouyang GL; Yi H; Li MY; Zhang PF; Li C; Li JL; Liu YF; Chen ZC; Xiao ZQ J Proteome Res; 2008 Dec; 7(12):5254-62. PubMed ID: 19367706 [TBL] [Abstract][Full Text] [Related]
25. CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway. Yang J; Lv X; Chen J; Xie C; Xia W; Jiang C; Zeng T; Ye Y; Ke L; Yu Y; Liang H; Guan XY; Guo X; Xiang Y Oncotarget; 2016 Mar; 7(13):15632-47. PubMed ID: 26701209 [TBL] [Abstract][Full Text] [Related]
26. [Expression of human cytochrome P450 2E1 gene in embryonic nasopharynx, nasopharyngeal cancer cell lines and tissue]. He ZM; Wang SL; Yuan JH; Chen ZC Ai Zheng; 2002 Jun; 21(6):597-600. PubMed ID: 12452057 [TBL] [Abstract][Full Text] [Related]
27. WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis. Qin L; Yin YT; Zheng FJ; Peng LX; Yang CF; Bao YN; Liang YY; Li XJ; Xiang YQ; Sun R; Li AH; Zou RH; Pei XQ; Huang BJ; Kang TB; Liao DF; Zeng YX; Williams BO; Qian CN Oncotarget; 2015 Apr; 6(12):10239-52. PubMed ID: 25823923 [TBL] [Abstract][Full Text] [Related]
28. The independent, unfavorable prognostic factors endothelin A receptor and chemokine receptor 4 have a close relationship in promoting the motility of nasopharyngeal carcinoma cells via the activation of AKT and MAPK pathways. Luo DH; Chen QY; Liu H; Xu LH; Zhang HZ; Zhang L; Tang LQ; Mo HY; Huang PY; Guo X; Mai HQ J Transl Med; 2013 Aug; 11():203. PubMed ID: 23987636 [TBL] [Abstract][Full Text] [Related]
29. Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma. Zhao Y; Zhang J; Tian Y; Xue C; Hu Z; Zhang L Drug Des Devel Ther; 2015; 9():4897-907. PubMed ID: 26345996 [TBL] [Abstract][Full Text] [Related]
30. CDC42-interacting protein 4 promotes metastasis of nasopharyngeal carcinoma by mediating invadopodia formation and activating EGFR signaling. Meng DF; Xie P; Peng LX; Sun R; Luo DH; Chen QY; Lv X; Wang L; Chen MY; Mai HQ; Guo L; Guo X; Zheng LS; Cao L; Yang JP; Wang MY; Mei Y; Qiang YY; Zhang ZM; Yun JP; Huang BJ; Qian CN J Exp Clin Cancer Res; 2017 Jan; 36(1):21. PubMed ID: 28129778 [TBL] [Abstract][Full Text] [Related]
31. Hes1 triggers epithelial-mesenchymal transition (EMT)-like cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway. Wang SC; Lin XL; Wang HY; Qin YJ; Chen L; Li J; Jia JS; Shen HF; Yang S; Xie RY; Wei F; Gao F; Rong XX; Yang J; Zhao WT; Zhang TT; Shi JW; Yao KT; Luo WR; Sun Y; Xiao D Oncotarget; 2015 Nov; 6(34):36713-30. PubMed ID: 26452025 [TBL] [Abstract][Full Text] [Related]
32. Proteomic analysis to identify cytokeratin 18 as a novel biomarker of nasopharyngeal carcinoma. Li XM; Huang WG; Yi H; Cheng AL; Xiao ZQ J Cancer Res Clin Oncol; 2009 Dec; 135(12):1763-75. PubMed ID: 19529960 [TBL] [Abstract][Full Text] [Related]
33. YPEL3 suppresses epithelial-mesenchymal transition and metastasis of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway. Zhang J; Wen X; Ren XY; Li YQ; Tang XR; Wang YQ; He QM; Yang XJ; Sun Y; Liu N; Ma J J Exp Clin Cancer Res; 2016 Jul; 35(1):109. PubMed ID: 27400785 [TBL] [Abstract][Full Text] [Related]
34. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC. Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847 [TBL] [Abstract][Full Text] [Related]
35. Berberine inhibits metastasis of nasopharyngeal carcinoma 5-8F cells by targeting Rho kinase-mediated Ezrin phosphorylation at threonine 567. Tang F; Wang D; Duan C; Huang D; Wu Y; Chen Y; Wang W; Xie C; Meng J; Wang L; Wu B; Liu S; Tian D; Zhu F; He Z; Deng F; Cao Y J Biol Chem; 2009 Oct; 284(40):27456-66. PubMed ID: 19651779 [TBL] [Abstract][Full Text] [Related]
36. Aberrant SATB1 expression is associated with Epstein-Barr virus infection, metastasis and survival in human nasopharyngeal cells and endemic nasopharyngeal carcinoma. Deng YF; Zhou DN; Pan ZY; Yin P Int J Clin Exp Pathol; 2014; 7(5):2454-61. PubMed ID: 24966956 [TBL] [Abstract][Full Text] [Related]
37. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. Cheng AL; Huang WG; Chen ZC; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Peng F; Duan CJ; Xiao ZQ J Proteome Res; 2008 Jun; 7(6):2415-26. PubMed ID: 18433155 [TBL] [Abstract][Full Text] [Related]
38. Heparanase is involved in the proliferation and invasion of nasopharyngeal carcinoma cells. Chen J; Zheng D; Shen J; Ruan J; Li A; Li W; Xie G; Luo X; Zhao P; Zheng H Oncol Rep; 2013 May; 29(5):1888-94. PubMed ID: 23467769 [TBL] [Abstract][Full Text] [Related]
39. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway. Hu W; Xiao L; Cao C; Hua S; Wu D Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030 [TBL] [Abstract][Full Text] [Related]
40. MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma. Liu N; Tang LL; Sun Y; Cui RX; Wang HY; Huang BJ; He QM; Jiang W; Ma J Cancer Lett; 2013 Feb; 329(2):181-8. PubMed ID: 23142282 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]